We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Mesoblast expects FDA stem cell drug approval by the first week of January ‘if not earlier’ FDA to...
Read ArticleInvestors in ASX healthcare shares have had reason to smile this earnings season, with plenty of str...
Read ArticleThe Mesoblast Ltd (ASX: MSB) share price is under pressure on Tuesday. At the time of writing, the a...
Read ArticleMesoblast Ltd (ASX: MSB) shares are at it again today. And by 'it', I mean racing higher. Shares in...
Read ArticleIt can be useful for investors to keep an eye on which shares have experienced meaningful insider bu...
Read ArticleThe ASX200 closed the day down a third of a per cent, weighed down mostly by IT with Healthcare and...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another gain. At th...
Read ArticleThe Australian Securities Exchange (ASX) is welcoming an AI exchange-traded fund (ETF) today. Ar...
Read ArticleASX healthcare stock SomnoMed (ASX:SOM), a provider of sleep-related breathing solutions for the med...
Read ArticleThe ASX 200 erases early morning’s losses, rallying to close the day +0.3% higher. This comes as th...
Read ArticleHere’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 2...
Read ArticleSomnoMed (ASX:SOM) appoints joint CEOs to accelerate growth SomnoMed aims to accelerate its reve...
Read ArticleThe local share market looks to rise half a per cent today off the back of records on Wall Street US...
Read ArticleASX 200 closes about 0.06% in the green (so, really, we ended in the chartreuse) down -1.2 in Augus...
Read ArticleIt’s quarterlies season again as the ASX market announcements page becomes increasingly flooded with...
Read ArticleToday, Wednesday the 24th of August, we are happy to buy ALS Ltd (ASX:ALQ), Breville Group Ltd (ASX:...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleIt’s quarterlies season as the ASX market announcements page becomes increasingly flooded with lodge...
Read ArticleHighlights The benchmark ASX 200 index fell 0.99% or to 7,245.7 in early trade. US stocks plung...
Read ArticleToday, Wednesday the 23rd of February, we are happy to buy Cochlear (ASX:COH), HUB24 (ASX:HUB), Cole...
Read ArticleAustralian medical device company and global supplier of rapid diagnostic testing devices (RDT), Ato...
Read ArticleAlloggio Group (ASX:ALO), didn’t have a positive debut on the ASX last week but that didn’t stop one...
Read ArticleSummary The S&P/ASX200 opened higher and gained 0.5% to hit an all-time high of 7,433.5. T...
Read ArticleWorld Overnight SPI Overnight (Jun) 7394.00 + 6.00 0.08% S&P ASX 200 7386.20 + 6.70 0.09%...
Read ArticleThe markets opened on a weak note on Tuesday morning. The benchmark ASX 200 was trading lower by 49...
Read ArticleToday, Wednesday the 24th of February, we are happy to buy APA Group (ASX:APA), HUB24 (ASX:HUB), Sup...
Read ArticleThe Somnomed Limited (ASX: SOM) share price closed 2.3% lower today at $2.12. While the SomnoMed sh...
Read ArticleThe Rhinomed Ltd (ASX: RNO) share price surged to a six-month high as it takes a leaf out of the St...
Read ArticleMichael Gable is an expert guest commentator for the Finance News Network, presenting “Stock Watch”...
Read ArticleWorld Overnight SPI Overnight (Sep) 6076.00 – 9.00 – 0.15% S&P ASX 200 6126.20 + 9.80 0.16...
Read ArticleShareCafeOvernight: Fly Me To The Moon World Overnight SPI Overnight (Sep) 6095.00 + 15.00 0.25%...
Read ArticleWorld Overnight SPI Overnight (Sep) 6095.00 + 15.00 0.25% S&P ASX 200 6116.40 – 45.00 – 0....
Read ArticleShareCafeOvernight: Normal Service Resumed World Overnight SPI Overnight (Sep) 6132.00 + 39.00 0...
Read ArticleWorld Overnight SPI Overnight (Sep) 6132.00 + 39.00 0.64% S&P ASX 200 6161.40 + 31.80 0.52...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((CNU)) - Chorus ((ASB)) - Aust...
Read ArticleSomnoMed (ASX:SOM) is the latest Australian health company to look to Silicon Valley for its board,...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleCOVID-19 has resulted in radical shifts in the health sector such as the adoption of tele-health, bu...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 134-odd small ca...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleOptimism is returning to the sleep apnoea market as Somnomed (ASX:SOM) says the nightmares that prom...
Read Article2020 was looking good for many companies but COVID-19 changed all that. Some have needed capital to...
Read ArticleSleep apnoea treatment company SomnoMed (ASX: SOM) was caught napping in 2018 when an ambitious US d...
Read ArticleSleep apnoea — or sleep suffocation as some have taken to calling it — is big business on the ASX, s...
Read ArticleThe venerable sleep disorders house is starting to sound like a car maker that has exhausted the pos...
Read ArticleThe SomnoMed Limited (ASX: SOM) share price has closed the trading day at a 52-week-high, after sur...
Read ArticleQuarterly reports for biotechs usually only tell investors how much cash they have left — and how mu...
Read ArticleMedical cannabis company Impression Healthcare (ASX: IHL) is continuing on its path to developing an...
Read ArticleAustralian-headquartered global pharmaceutical leader, SUDA Pharmaceuticals Limited (ASX: SUD) is en...
Read ArticleAs the head of a company selling mouthguard-like oral devices to combat obstructive sleep apnoea (OS...
Read ArticleImugene Limited (ASX: IMU), an Australian-headquartered clinical-stage immuno-oncology company, focu...
Read ArticlePrescient Therapeutics Limited (ASX: PTX) is an Australian clinical stage oncology company that is i...
Read ArticleIn this week’s recap of substantial holders, Australian Super became an substantial holder in Gage R...
Read ArticleIn this article, we would discuss three healthcare stocks from ASX. On 23 July 2019, these companies...
Read ArticleThe Somnomed Limited (ASX: SOM) share price opened 6.7% higher at $1.60 today after the sleep treat...
Read ArticleHealth and medical industry of Australia focuses on the world’s leading technology, advanced researc...
Read ArticleInvestors might be taking a closer at Somnomed Limited (ASX: SOM), a healthcare business. Somnomed w...
Read ArticleIn morning trade the Volpara Health Technologies Ltd (ASX: VHT) share price has charged higher foll...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
